GO:1900245 positive regulation of MDA-5 signaling pathway: Antiviral Immunity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900245 describes any process that activates or increases the frequency, rate or extent of the MDA-5 signaling pathway, the cytosolic dsRNA-sensing cascade that triggers type I interferon and NF-kB responses.
• MDA-5 (encoded by IFIH1) is a viral stress-inducible RIG-I-like receptor (RLR) that recognizes long double-stranded RNA and initiates MAVS-dependent antiviral signaling.
• Positive regulation of MDA-5 signaling is essential for host defense against RNA viruses such as rhinovirus, Zika virus and other respiratory and neurotropic pathogens.
• Negative regulators such as SLIRP and multiple viral evasion proteins tightly control MDA-5 signaling to prevent autoimmunity and excessive inflammation.
• Dysregulated MDA-5 signaling is linked to asthma exacerbation, psoriasis, autoimmune diseases and viral immune evasion, making it a therapeutic target.
• CRISPR knockout, point-mutation, knock-in and overexpression models are key tools for dissecting positive regulators of the MDA-5 pathway.
Description
The Gene Ontology term GO:1900245, positive regulation of MDA-5 signaling pathway, refers to any process that activates or increases the frequency, rate or extent of the MDA-5 signaling pathway. MDA-5, also known as IFIH1 or melanoma differentiation-associated gene 5, is a cytosolic pattern-recognition receptor that detects long double-stranded RNA generated during RNA virus infection. Upon ligand binding, MDA-5 undergoes conformational activation and assembles into filaments that signal through the mitochondrial antiviral signaling protein MAVS, leading to activation of IRF3/IRF7 and NF-kB and subsequent production of type I interferons and pro-inflammatory cytokines. This pathway is a cornerstone of innate antiviral immunity and is therefore subject to extensive positive and negative regulation. Because MDA-5 signaling must be rapidly amplified to control viral replication yet tightly restrained to avoid autoimmune pathology, positive regulators of this pathway are of intense research interest. Genetic and pharmacological studies have identified both host factors that amplify MDA-5 signaling and viral proteins that antagonize it. For example, SLIRP has been shown to amplify antiviral signaling via a positive feedback mechanism and contributes to autoimmune diseases, while Zika virus NS2A and NS4A strongly downregulate NF-kB promoter activity, illustrating viral evasion of MDA-5-dependent responses. Understanding GO:1900245 is therefore central to virology, immunology and drug discovery. Researchers use CRISPR-based knockout, point-mutation, knock-in and overexpression models to determine whether candidate genes causally enhance MDA-5 signaling and to map the molecular steps that convert dsRNA sensing into a protective interferon response.
positive regulation of MDA-5 signaling pathway At A Glance
| GO ID | GO:1900245 |
|---|---|
| GO term | positive regulation of MDA-5 signaling pathway |
| Ontology | biological_process |
| Synonym | activation of IFIH1 signaling pathway; activation of MDA-5 signaling pathway; positive regulation of MDA5 signaling pathway; upregulation of melanoma differentiation-associated gene 5 signaling pathway |
| Major function | Amplification of cytosolic dsRNA sensing to drive type I interferon and NF-kB antiviral responses |
| Key receptor | MDA-5 (IFIH1), a RIG-I-like receptor |
| Key adaptor | MAVS (mitochondrial antiviral signaling protein) |
| Downstream effectors | IRF3, IRF7, NF-kB, type I interferons |
| Representative positive regulator | SLIRP, which amplifies antiviral signaling via positive feedback |
| Disease relevance | Asthma, psoriasis, autoimmune diseases, viral evasion |
What Is GO:1900245?
In our own words, GO:1900245 encompasses any biological process that positively regulates the MDA-5 signaling pathway, meaning it increases the frequency, rate or extent of the signaling cascade initiated by the MDA-5 (IFIH1) receptor. This includes processes that promote MDA-5 ligand binding, MDA-5 oligomerization, MAVS recruitment, downstream IRF3/IRF7 and NF-kB activation, or interferon-stimulated gene expression. The term is a biological_process child of positive regulation of signal transduction and is synonymous with activation or upregulation of IFIH1/MDA-5 signaling.
Why Is positive regulation of MDA-5 signaling pathway Important in Cell Biology?
Positive regulation of MDA-5 signaling is critically important because it determines the strength and duration of the innate immune response to RNA viruses. Without adequate amplification, viruses such as rhinovirus and Zika virus can evade detection and replicate unchecked. Conversely, excessive or uncontrolled MDA-5 activation can break immune tolerance and contribute to autoimmune and inflammatory diseases, including psoriasis and asthma exacerbations. Thus, understanding the positive regulators of this pathway offers dual therapeutic opportunities: enhancing antiviral immunity where it is deficient and dampening it where it drives pathology.
• Controls type I interferon production during RNA virus infection.
• Essential for host defense against rhinovirus, a major asthma trigger.
• Targeted by viral evasion proteins such as Zika NS2A and NS4A.
• Amplified by host factors like SLIRP, linking to autoimmune disease.
• Dysregulated in psoriasis, where MDA-5 pathway inhibition is therapeutic.
• Provides a mechanistic basis for antiviral drug and immunotherapy development.
• Serves as a model for studying RLR signaling amplification and feedback.
• Informs CRISPR-based functional genomics of innate immunity.
What Happens During positive regulation of MDA-5 signaling pathway?
dsRNA recognition and MDA-5 activation
In simple terms: MDA-5 acts like a smoke detector for viral RNA; positive regulation makes it more sensitive and quicker to sound the alarm.
MDA-5 (IFIH1) is a cytosolic RIG-I-like receptor that binds long double-stranded RNA, a common viral replication intermediate. Positive regulation of this step can involve increased MDA-5 expression, enhanced ligand binding affinity, or post-translational modifications that stabilize the active conformation. Viral stress-inducible genes, including MDA-5 itself, are upregulated by interferons, creating a feed-forward loop that amplifies sensing.
MDA-5 oligomerization and MAVS signalosome assembly
In simple terms: Once MDA-5 detects viral RNA, it clusters together and recruits a relay protein called MAVS to start the alarm cascade.
Upon dsRNA binding, MDA-5 forms helical filaments that present caspase activation and recruitment domains (CARDs) for MAVS binding. Positive regulators can promote filament nucleation, stabilize oligomers, or facilitate MAVS aggregation on mitochondria. MAVS then serves as a signaling hub for downstream kinases TBK1 and IKK, which activate IRF3/IRF7 and NF-kB, respectively.
IRF3/IRF7 and NF-kB activation
In simple terms: The signal travels to transcription factors that switch on antiviral genes, including interferon.
MAVS-dependent signaling leads to phosphorylation and nuclear translocation of IRF3 and IRF7, which induce type I interferon genes, and NF-kB, which induces pro-inflammatory cytokines. Positive regulation of MDA-5 signaling increases the magnitude of these transcriptional responses. Zika virus NS2A and NS4A can strongly downregulate NF-kB promoter activity, counteracting this positive regulation.
Interferon-stimulated gene feedback amplification
In simple terms: The interferon produced by MDA-5 signaling makes more MDA-5 and other antiviral proteins, creating a positive feedback loop.
Secreted type I interferons act in autocrine and paracrine manners to induce interferon-stimulated genes (ISGs), including MDA-5 itself, thereby amplifying the pathway. SLIRP has been shown to amplify antiviral signaling via positive feedback regulation and contributes to autoimmune diseases, illustrating how host factors can enhance this loop.
Negative regulation and viral evasion as a counterbalance
In simple terms: Brakes exist to stop the alarm from ringing forever; viruses often cut these brakes or jam the signal.
Negative regulators of RLR signaling, including SLIRP and other host proteins, prevent excessive inflammation and autoimmunity. Viruses encode proteins that antagonize MDA-5 signaling; for example, Zika virus NS2A and NS4A downregulate NF-kB promoter activity. Understanding positive regulation requires knowing these opposing forces.
Key Genes Involved in GO:1900245 positive regulation of MDA-5 signaling pathway
The following genes and proteins are central to the positive regulation of MDA-5 signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IFIH1 (MDA-5) | Cytosolic dsRNA sensor; initiator of the pathway | Core receptor; target for gain-of-function and loss-of-function studies |
| MAVS | Mitochondrial adaptor; signalosome assembly | Essential downstream node; knockout abolishes signaling |
| TBK1 | Kinase activating IRF3/IRF7 | Positive regulator; drug target |
| IKK (CHUK/IKBKB) | Kinase activating NF-kB | Positive regulator of inflammatory arm |
| IRF3 | Transcription factor inducing IFN-beta | Effector of antiviral gene program |
| IRF7 | Transcription factor amplifying IFN-alpha | Positive feedback regulator |
| SLIRP | Amplifies antiviral signaling via positive feedback | Links MDA-5 pathway to autoimmune disease |
| ESRRA | Nuclear receptor regulating transcriptional programs | Potential modifier of interferon-stimulated genes |
| NS2A (Zika) | Viral protein downregulating NF-kB | Evasion factor; model for inhibition |
| NS4A (Zika) | Viral protein downregulating NF-kB | Evasion factor; model for inhibition |
| DDX58 (RIG-I) | Related RLR sensor | Cross-talk with MDA-5 pathway |
| TRIM25 | E3 ligase promoting RLR signaling | Positive regulator of RLRs |
| USP family | Deubiquitinases stabilizing RLRs | Positive regulators |
| ATG5-ATG12 | Autophagy-related modulator of RLR signaling | Negative/positive context-dependent |
| NLRX1 | Mitochondrial negative regulator | Counterbalance to positive regulation |
| SOCS proteins | Suppressors of cytokine signaling | Negative feedback on interferon |
How Is positive regulation of MDA-5 signaling pathway Regulated?
Positive regulation of MDA-5 signaling is itself regulated at multiple levels. Interferon signaling induces MDA-5 expression, creating a feed-forward amplification loop. Post-translational modifications, including ubiquitination and phosphorylation, modulate MDA-5 and MAVS activity. Host proteins such as SLIRP amplify signaling via positive feedback and are linked to autoimmune diseases. Conversely, negative regulators and viral proteins such as Zika NS2A/NS4A dampen the pathway to prevent excessive inflammation or to evade immunity. This balance is critical for immune homeostasis.
positive regulation of MDA-5 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IFIH1 (MDA-5) | Asthma exacerbation by rhinovirus | Airway epithelial KO and overexpression |
| SLIRP | Autoimmune diseases | Knockout and knock-in in immune cells |
| MDA-5 pathway | Psoriasis | Keratinocyte models with pathway modulation |
| NS2A/NS4A | Zika virus immune evasion | Viral protein overexpression in reporter cells |
| ESRRA | ER-alpha-positive breast cancer | Knockout and overexpression in cancer lines |
Asthma and rhinovirus infection
Rhinovirus is a major trigger of asthma exacerbations, and MDA-5 signaling is central to anti-rhinovirus immunity. Positive regulation of MDA-5 signaling enhances interferon responses that limit viral replication, but excessive inflammation can worsen airway disease. Understanding these dynamics may inform therapies for virus-induced asthma.
Psoriasis and autoimmune diseases
The MDA-5 pathway contributes to psoriasis pathogenesis; Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis via downregulation of the MDA-5 pathway. SLIRP amplifies antiviral signaling and contributes to autoimmune diseases, highlighting how positive regulators can drive autoimmunity. Targeting positive regulators may offer therapeutic benefit in these conditions.
Viral evasion and emerging infections
Zika virus NS2A and NS4A strongly downregulate NF-kB promoter activity, counteracting MDA-5-mediated antiviral responses. Other viruses also encode antagonists of RLR signaling. Understanding positive regulation helps identify viral vulnerabilities and host-directed antiviral targets.
From positive regulation of MDA-5 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X a positive regulator of MDA-5 signaling? | CRISPR knockout followed by dsRNA stimulation and IFN reporter assay |
| Does a point mutation in IFIH1 alter signaling? | Point-mutation knock-in in cell lines |
| Does tagging endogenous MDA-5 affect localization? | Tagged knock-in (e.g., GFP) |
| Does overexpression of SLIRP amplify antiviral signaling? | Overexpression cell model |
| Which viral proteins inhibit NF-kB downstream of MDA-5? | Overexpression of viral proteins in reporter cells |
| Can CRISPR library screening identify novel positive regulators? | Genome-wide CRISPR screen with viral infection readout |
How to Study the positive regulation of MDA-5 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| IFN-beta luciferase reporter | Type I interferon promoter activity | Screening positive regulators |
| NF-kB luciferase reporter | NF-kB transcriptional activity | Viral evasion studies |
| CRISPR knockout | Gene requirement for signaling | Functional genomics |
| Point-mutation knock-in | Domain-specific function | Mechanistic dissection |
| Overexpression | Sufficiency to activate pathway | Gain-of-function studies |
| RNA-seq | Global gene expression changes | Interferon-stimulated gene profiling |
| Proteomics | Protein complex composition | MAVS signalosome analysis |
| Imaging | Subcellular localization | MDA-5 filament visualization |
Reporter assays for interferon and NF-kB
Luciferase reporters driven by IFN-beta or NF-kB promoters are widely used to measure MDA-5 signaling activity after dsRNA stimulation or viral infection. These assays can be combined with CRISPR knockout to test candidate positive regulators.
CRISPR knockout and point-mutation models
Knockout of candidate genes followed by dsRNA stimulation reveals whether the gene is required for MDA-5 signaling. Point mutations can dissect specific domains or post-translational modification sites.
Overexpression and knock-in models
Overexpression of host or viral proteins can test sufficiency for pathway activation or inhibition. Tagged knock-in allows visualization of endogenous protein dynamics.
Transcriptomics and proteomics
RNA-seq and proteomics can identify interferon-stimulated genes and signaling complexes downstream of MDA-5 activation. These approaches help map the broader regulatory network.
How CRISPR Can Be Used to Study GO:1900245 positive regulation of MDA-5 signaling pathway
Knockout
CRISPR knockout of candidate genes such as SLIRP or IFIH1 can determine whether they are required for positive regulation of MDA-5 signaling. Cells are stimulated with dsRNA or infected with virus, and interferon or NF-kB reporters are measured.
Point Mutation
Point mutations can be introduced into IFIH1 or MAVS to test the role of specific residues in signaling amplification. This is useful for dissecting gain-of-function variants associated with autoimmunity.
Knock-in
Tagged knock-in of MDA-5 or MAVS allows real-time tracking of endogenous protein localization and complex formation during signaling.
Overexpression
Overexpression of positive regulators such as SLIRP or of viral inhibitors such as Zika NS2A/NS4A can test sufficiency for pathway enhancement or suppression.
How EDITGENE Supports positive regulation of MDA-5 signaling pathway Research
Researchers studying positive regulation of MDA-5 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in amplifying or dampening the antiviral response. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of MDA-5 signaling pathway research.
Frequently Asked Questions About positive regulation of MDA-5 signaling pathway
What is GO:1900245 positive regulation of MDA-5 signaling pathway?
It is a Gene Ontology biological process term describing any process that activates or increases the frequency, rate or extent of the MDA-5 signaling pathway, which senses viral dsRNA and triggers interferon responses.
What genes are involved in positive regulation of MDA-5 signaling?
Key genes include IFIH1 (MDA-5), MAVS, TBK1, IKK, IRF3, IRF7 and positive regulators such as SLIRP.
How is MDA-5 signaling activated?
MDA-5 binds long double-stranded RNA, oligomerizes, and recruits MAVS to activate TBK1/IKK, leading to IRF3/IRF7 and NF-kB-dependent gene expression.
What diseases are linked to MDA-5 signaling?
Asthma exacerbations by rhinovirus, psoriasis, autoimmune diseases and viral immune evasion are linked to MDA-5 signaling.
How do viruses evade MDA-5 signaling?
Viruses encode proteins such as Zika NS2A and NS4A that downregulate NF-kB promoter activity, counteracting MDA-5-mediated antiviral responses.
What is the role of SLIRP in MDA-5 signaling?
SLIRP amplifies antiviral signaling via positive feedback regulation and contributes to autoimmune diseases.
Can CRISPR be used to study MDA-5 signaling?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to dissect positive regulators of MDA-5 signaling.
What cell models are suitable for MDA-5 research?
Airway epithelial cells, immune cells, keratinocytes and reporter cell lines are commonly used, depending on the disease context.
How is MDA-5 signaling measured?
Reporter assays for IFN-beta and NF-kB, RNA-seq, proteomics and imaging are standard methods.
Why is positive regulation of MDA-5 signaling important?
It determines the strength of antiviral immunity and must be balanced to avoid autoimmunity and inflammatory disease.
Conclusion
GO:1900245 positive regulation of MDA-5 signaling pathway is a critical biological process that amplifies cytosolic dsRNA sensing to mount effective antiviral and inflammatory responses. Its dysregulation is implicated in asthma, psoriasis, autoimmune diseases and viral evasion, making it a high-value target for basic and translational research. By leveraging CRISPR knockout, point-mutation, knock-in and overexpression models, researchers can causally dissect the positive regulators of this pathway and accelerate the development of host-directed antivirals and immunomodulators.
References
- 1. Sen GC et al.. 2007. Viral stress-inducible genes.. Adv Virus Res 70:233-63 PMID: 17765707
- 2. Yang Z et al.. 2021. Mechanism of Rhinovirus Immunity and Asthma.. Front Immunol 12:731846 PMID: 34691038
- 3. Quicke KM et al.. 2017. Negative regulators of the RIG-I-like receptor signaling pathway.. Eur J Immunol 47(4):615-628 PMID: 28295214
- 4. Ku D et al.. 2025. SLIRP amplifies antiviral signaling via positive feedback regulation and contributes to autoimmune diseases.. Cell Rep 44(5):115588 PMID: 40253699
- 5. Zheng ZZ et al.. 2025. Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs.. Sci Bull (Beijing) 70(22):3822-3839 PMID: 41111053
- 6. Wang G et al.. 2024. Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis in psoriasis via downregulating the MDA-5 pathway.. J Ethnopharmacol 328:118059 PMID: 38508430
- 7. Lee HC et al.. 2019. Intracellular sensing of viral genomes and viral evasion.. Exp Mol Med 51(12):1-13 PMID: 31827068
- 8. Lee JY et al.. 2020. Zika Virus-Encoded NS2A and NS4A Strongly Downregulate NF-κB Promoter Activity.. J Microbiol Biotechnol 30(11):1651-1658 PMID: 33203823
